Table 1.

Monitoring guidelines for comorbidities in pediatric psoriasis

Comorbidity	Guidelines
Obesity	Screen for overweight and obesity using BMI criteria at two years of age
Type 2 diabetes	Screen obese children or overweight using fasting serum glucose with risk factors every three years starting at age ten years or puberty onset
Dyslipidemia	Screen children ages 9-11 years and aged 17-21 years using fasting lipid panel
	Otherwise: screen children with cardiovascular risk factors
Hypertension	Screen yearly starting at age three years (age/sex/height reference charts)
Nonalcoholic fatty liver disease	Screen obese children overweight with risk factors using ALT starting at age 9-11 years, consider repeating in two to three years
Mood changes	Screen yearly for depression and anxiety regardless of age.
	Screen yearly for substance abuse starting at age 11 years.